Skip to main content

What the FDA labels say about taking them together

Dexlansoprazole and rifampin

Dexlansoprazole's FDA label of February 17, 2025 names rifampin in its drug interactions section; the rifampin label PlainMeds reads does not name dexlansoprazole. The dexlansoprazole label: “Decreased exposure of dexlansoprazole when used concomitantly with strong inducers.”

Check it at the source: the dexlansoprazole FDA label on DailyMed (effective February 17, 2025, Takeda Pharmaceuticals America, Inc.); the rifampin FDA label on DailyMed (effective February 11, 2026, Lupin Pharmaceuticals, Inc.).

What does the dexlansoprazole label say about rifampin?

Dexlansoprazole label, drug interactions

Clinical Impact: Decreased exposure of dexlansoprazole when used concomitantly with strong inducers. Intervention: St. John's Wort, rifampin: Avoid concomitant use with DEXILANT. Ritonavir-containing products: See prescribing information. CYP2C19 or CYP3A4 Inhibitors

Source: FDA drug label (Dexilant), Takeda Pharmaceuticals America, Inc., effective February 17, 2025 (SPL set 9819f033-3bbe-442e-8e92-45fec77b237d), via openFDA; the full label on DailyMed

What does the rifampin label say about dexlansoprazole?

Rifampin's label (effective February 11, 2026) does not name dexlansoprazole in these sections. A label lists what its studies and reports found; it is not a complete list.

Source: FDA drug label (rifampin), Lupin Pharmaceuticals, Inc., effective February 11, 2026 (SPL set b56004f0-f23d-47f6-80c7-39884fccbccc), via openFDA; the full label on DailyMed

These are the labels' own sentences. PlainMeds does not grade interactions; a pharmacist or prescriber can say what they mean for one person's medicines.

Both medicines on the record

9Dexlansoprazole generic labelers
13Rifampin generic labelers
DexlansoprazoleRifampin
Labeled forAcid reflux and ulcersn/a
Boxed warningNoNo
Pharmacy cost (NADAC)$3.71 per capsule 60 mg capsule$0.679 per capsule 300 mg capsule
Shortage nowNo current entryIn shortage

Source: FDA NDC Directory, CMS NADAC of October 7, 2026 and the FDA Drug Shortage Database (FDA files October 8, 2026)

What next?